BREAKING NEWS

Oxford to study popular prescription drug as potential COVID-19 treatment

By REUTERS

SEPTEMBER 30, 2020 12:21

Britain's Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients, the latest effort to repurpose existing drugs as potential coronavirus therapies.

The AVID-CC trial will test the anti-tumor necrosis factor (anti-TNF) drug and will be aimed at treating people in the community, especially in care homes. It will enroll up to 750 patients from community care settings throughout the UK.

IDF, Hezbollah exchange fire on Lebanon border

By JERUSALEM POST STAFF

04/26/2024 01:22 AM

Bernie Sanders to Netanyahu: you are using antisemitism as a distraction

By JERUSALEM POST STAFF

04/26/2024 12:33 AM

Yeshiva University re-opens admissions amid safety concerns on campuses

By JERUSALEM POST STAFF

04/26/2024 12:19 AM

US preparing to announce $6b in weapons for Ukraine, Politico reports

By REUTERS

04/26/2024 12:12 AM